JP2022548530A5 - - Google Patents
Info
- Publication number
- JP2022548530A5 JP2022548530A5 JP2022514767A JP2022514767A JP2022548530A5 JP 2022548530 A5 JP2022548530 A5 JP 2022548530A5 JP 2022514767 A JP2022514767 A JP 2022514767A JP 2022514767 A JP2022514767 A JP 2022514767A JP 2022548530 A5 JP2022548530 A5 JP 2022548530A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- alkylene
- groups
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382765 | 2019-09-05 | ||
| EP19382765.6 | 2019-09-05 | ||
| PCT/EP2020/074695 WO2021043951A1 (en) | 2019-09-05 | 2020-09-04 | Drug antibody conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548530A JP2022548530A (ja) | 2022-11-21 |
| JP2022548530A5 true JP2022548530A5 (cg-RX-API-DMAC10.html) | 2023-09-11 |
Family
ID=67902467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514767A Pending JP2022548530A (ja) | 2019-09-05 | 2020-09-04 | 薬物抗体コンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230218774A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4025253B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022548530A (cg-RX-API-DMAC10.html) |
| CN (1) | CN114615999B (cg-RX-API-DMAC10.html) |
| TW (1) | TW202122116A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021043951A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119490650B (zh) * | 2023-08-17 | 2026-08-11 | 上海交通大学 | 自由基光偶联方法、用于实现光偶联的试剂盒与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| DE69308573T2 (de) | 1992-08-17 | 1997-08-07 | Genentech Inc | Bispezifische immunoadhesine |
| CA2249195A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| ES2369542T3 (es) | 2002-07-31 | 2011-12-01 | Seattle Genetics, Inc. | Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa. |
| JP4993645B2 (ja) | 2004-12-01 | 2012-08-08 | ジェネンテック， インコーポレイテッド | 抗体薬剤結合体および方法 |
| US7811572B2 (en) | 2005-08-24 | 2010-10-12 | Immunogen, Inc. | Process for preparing purified drug conjugates |
| US9364555B2 (en) * | 2011-07-22 | 2016-06-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Pederin and psymberin agents |
| MX392144B (es) * | 2017-03-17 | 2025-03-21 | Pharma Mar Sa | Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer. |
-
2020
- 2020-09-04 JP JP2022514767A patent/JP2022548530A/ja active Pending
- 2020-09-04 US US17/640,689 patent/US20230218774A1/en not_active Abandoned
- 2020-09-04 CN CN202080062337.9A patent/CN114615999B/zh not_active Expired - Fee Related
- 2020-09-04 TW TW109130445A patent/TW202122116A/zh unknown
- 2020-09-04 WO PCT/EP2020/074695 patent/WO2021043951A1/en not_active Ceased
- 2020-09-04 EP EP20764406.3A patent/EP4025253B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512830A5 (cg-RX-API-DMAC10.html) | ||
| HRP20230275T1 (hr) | Antitijelo-lijek konjugati koji sadrže derivate ekteinascidina | |
| JP7703727B2 (ja) | 抗ｈｅｒ２抗体－薬物コンジュゲート | |
| AU2019349207B2 (en) | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof | |
| JP2024508081A (ja) | 生物活性物質コンジュゲート、その調製方法及びその使用 | |
| JP2023522259A5 (cg-RX-API-DMAC10.html) | ||
| EP4556026A1 (en) | Antibody-drug conjugate, and preparation method therefor and use thereof | |
| CN115515642A (zh) | 抗cd56抗体-药物偶联物及其在治疗中的用途 | |
| CN116999572A (zh) | 抗体－药物偶联物、药物组合物及其在制备治疗肿瘤的药物中的应用 | |
| JP7827624B2 (ja) | 抗ｃｅａ抗体－エキサテカン類似体複合体及びその医薬用途 | |
| AU2021282669A1 (en) | Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof | |
| RU2015156499A (ru) | Конъюгаты антитела с лекарственным средством | |
| JP2023519776A5 (cg-RX-API-DMAC10.html) | ||
| JP2019507126A5 (cg-RX-API-DMAC10.html) | ||
| JP2026508115A (ja) | リンカー薬物、その抗体－薬物コンジュゲート、並びにそれらの調製方法及び使用 | |
| CN120225226A (zh) | B7-h3抗体药物偶联物及其应用 | |
| TH2101002347A (th) | คอนจูเกตแอนติบอดียา (Drug Antibody Conjugates) | |
| AU2022350725A1 (en) | Antibody-drug conjugate, preparation method therefor, and pharmaceutical use thereof | |
| CN119816522B (zh) | 5t4抗体药物偶联物及其应用 | |
| WO2025226868A1 (en) | Antibody drug conjugates and uses thereof | |
| WO2025218776A1 (zh) | 抗ror1抗体、其免疫缀合物及其应用 | |
| CN119701002A (zh) | 一类抗体药物偶联物、其药物组合物及应用 | |
| HK40086489A (en) | Anti-her2 antibody-drug conjugate | |
| HK40112172A (en) | Anti-her2 antibody-drug conjugate | |
| HK40005802A (en) | Anti-her2 antibody-drug conjugate |